Stroke device could revolutionize heart attack treatment

NCT ID NCT05307965

Completed Disease control Sponsor: Oxford University Hospitals NHS Trust Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested a stent retriever device, already used for strokes, to remove clots during heart attacks. The goal was to reduce damage to small heart blood vessels caused by clot fragments. 81 patients with severe heart attacks were enrolled to see if the device works better than standard clot removal methods.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Stent retriever device (SolitaireTM X Revascularisation Device)
What this could lead to: If it works, this could offer a better way to remove clots during heart attacks, potentially reducing long-term heart damage and improving recovery.
What could go wrong: This is a small, early-stage trial with only 81 participants. The device may not work better than standard care, and there are risks like vessel damage or complications during the procedure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder myocardial infarction ST-elevation myocardial infarction thrombotic disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY ARTERY DISEASE MYOCARDIAL INFARCTION THROMBUS

Contacts and locations

Locations

Oxford Heart Centre

Oxford, OX3 9DU, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.